An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
Clinical trial NCT02676401 · COMPLETED
Trial details
- NCT number
- NCT02676401
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-08-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.